India

FDA crackdown on Cipla Pharma's Pune unit,license cancelled over 'unauthorised promotional text'

The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.

This story summarizes reporting from Hindustan Times. Read the original for full context. Wire items stay in our news sitemap for seven days. Editorial policy.

Read full story on Hindustan Times →

Hindustan Times28 Aug 2026, 01:45 pmUpdated 4h ago1 min readIndiaIndia

India — Hindustan Times

FDA crackdown on Cipla Pharma's Pune unit, license cancelled over 'unauthorised promotional text'

The FDA seized Reactin Plus stock worth ₹11.19 lakh and ordered the firm to recall the drug from the market.

This report is published with credit to Hindustan Times. The wire sent a summary; open the original for any extra context. Read on Hindustan Times →

Source: Hindustan Times. Published 28 Aug 2026, 01:45 pm.

Next news → DGP lays foundation stone for ‘Vihara’, ‘V…Browse more stories

Keep reading

Most relevant

DGP lays foundation stone for ‘Vihara’, ‘Vihari’ and Central police canteen at Mangalagiri

Back to the desk

info@ebenezerdigital.com +91 98944 96560 WhatsApp

FDA crackdown on Cipla Pharma's Pune unit,license cancelled over 'unauthorised promotional text'

Keep reading

DGP lays foundation stone for ‘Vihara’, ‘Vihari’ and Central police canteen at Mangalagiri

Engineering students urged to plan careers from first year

Shots fired at Goa casino director, he escapes unhurt